Prostate-Specific Antigen (PSA) Test Market Segments, Top Key Players, Drivers And Trends 2022

According to Precision Business Insights (PBI), the latest report the Global Prostate-Specific Antigen (PSA) Test Market is expected to be worth USD 3,276.9 million in 2021 and is projected to grow at a 11.5% CAGR over 2022 to 2028. The prostate-specific antigen (PSA) testing market is expected to expand due to increased awareness of the availability of improved cancer diagnostics technologies, particularly in emerging markets. However, increased diseases prevalence will have a considerable influence on market development. Furthermore, supporting actions from various governments throughout the world fuel market expansion.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/prostate-specific-antigen-test-market/

The CLIA Method Segment is Dominating the Global Prostate-Specific Antigen (PSA) Test Market
The CLIA method segment is anticipated to account for a significant share, and the market is anticipated to grow at a double-digit growth rate over the forecast years owing to the chemiluminescence immunoassay (CLIA) is used in test Kits used for detecting glow-based chemiluminescent processes. The kits outperform traditional colorimetric techniques in terms of dynamic assay range, low-end sensitivity, and speed. Chemiluminescence Immunoassay (CLIA) detection employing Microplate luminometers is a sensitive, high-throughput, and cost-effective alternative to traditional colorimetric methods such as enzyme-linked immunosorbent assays (ELISA). ELISA uses a label enzyme and a colorimetric substrate to provide an amplified signal for antigen, hapten, or antibody quantification. This approach is well established and widely used in diagnostics test kits, research, food testing, process quality assurance and control, and environmental testing.

North America Leads Global Prostate-Specific Antigen (PSA) Test Market:
North America is expected to hold significant market share in the Global Prostate-Specific Antigen (PSA) Test Market and is projected to grow at a prominent growth rate over the forecast years owing to the growing high mortality rate in various developed nations, as well as the growing prevalence of prostate cancer in this area, will drive the expansion of the Prostate Specific Antigen (PSA) Testing Market in the future years. Furthermore, increased government attention to prostate cancer diagnosis and improvement in healthcare is expected to drive the expansion of the region's Prostate Specific Antigen (PSA) Testing Market.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=59346

Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players:
Global Prostate-Specific Antigen (PSA) Test Market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In September 2021: Boston Scientific Corporation announced the EPOCH clinical trial of the TheraSphere Y-90 Glass Microspheres successfully met both primary endpoints, including progression-free survival (PFS) and hepatic progression-free survival (hPFS) of patients with metastatic colorectal cancer (mCRC) of the liver. In October 2019: GE Healthcare announced a global commercial partnership with Theragnostic for a new Prostate-Specific Membrane Antigen (PSMA) PET/CT imaging agent.

The global prostate-specific antigen (psa) test market is segmented based on types, applications, and geography.
Based on the type, the market is segmented into the following:
• CLIA Method
• ELISA Method

Based on the applications, the market is segmented into the following:
• Screening
• Post-treatment monitoring
• Others

Based on Geography, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=59346

Key player's profiles in the Abbott, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, Mediwatch (LABORIE), BodiTech, Bristol-Myers Squibb Company, GE Healthcare, Endocare, GlaxoSmithKline, Anixa Biosciences, Ortho Clinical, Fujirebio, Pharmacia Delfia.

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.